371 related articles for article (PubMed ID: 6119681)
21. The effect of alpha-adrenolytics on central action of agonists and antagonists of dopaminergic system.
Zebrowska-Lupina I
Pol J Pharmacol Pharm; 1977; 29(4):393-404. PubMed ID: 20609
[TBL] [Abstract][Full Text] [Related]
22. Indirect activation of the DA system as a possible mechanism for the stimulatory effects of narcotic analgesics.
Di Chiara G; Vargiu L; Porceddu ML; Longoni R; Mulas A; Gessa GL
Adv Biochem Psychopharmacol; 1977; 16():571-5. PubMed ID: 18901
[No Abstract] [Full Text] [Related]
23. Studies on the mechanism of post-etorphine catalepsy. Modyfying effect of amphetamine, apomorphine and dihydroxy-phenylalanine (L-dopa) on etorphine-induced concentrations of dopamine and noradrenaline in the rat central nervous system.
Kania BF
Acta Physiol Pol; 1979; 30(2):279-87. PubMed ID: 572616
[TBL] [Abstract][Full Text] [Related]
24. [Effect of dopaminergic substances on the antinocifensive action of arecoline].
Kraft U; Kraft H; Andreas K
Acta Biol Med Ger; 1979; 38(4):649-52. PubMed ID: 525142
[TBL] [Abstract][Full Text] [Related]
25. Studies on the participation of the dopaminergic system in the central effects of chronically administered antidepressant drugs.
Kozyrska C; Zebrowska-Lupina I
Pol J Pharmacol Pharm; 1983; 35(2):115-26. PubMed ID: 6684769
[TBL] [Abstract][Full Text] [Related]
26. Effects of buspirone on dopamine dependent behaviours in rats.
Dhavalshankh AG; Jadhav SA; Gaikwad RV; Gaonkar RK; Thorat VM; Balsara JJ
Indian J Physiol Pharmacol; 2007; 51(4):375-86. PubMed ID: 18476392
[TBL] [Abstract][Full Text] [Related]
27. [Influence of piracetam on the effects of narcotic analgesics and opioid peptides].
Krylova IN; Drozd IuV; Naumova VI; Iasnetsov VV; Shashkov VS
Farmakol Toksikol; 1988; 51(2):42-5. PubMed ID: 2897934
[TBL] [Abstract][Full Text] [Related]
28. The neurosteroid 3 alpha-hydroxy-5 alpha-pregnan-20-one affects dopamine-mediated behavior in rodents.
Khisti RT; Deshpande LS; Chopde CT
Psychopharmacology (Berl); 2002 May; 161(2):120-8. PubMed ID: 11981591
[TBL] [Abstract][Full Text] [Related]
29. Interaction of fibrinopeptides A and B with dopaminergic receptors in central nervous system.
Wawrzyniuk I; Buczko W; Wiśniewski K
Pol J Pharmacol Pharm; 1979; 31(4):365-72. PubMed ID: 574959
[TBL] [Abstract][Full Text] [Related]
30. Action of fibrinopeptides A and B on the central dopaminergic system of rats pretreated with indomethacin.
Swiderska D; Buczko W; Wiśniewski K
Pol J Pharmacol Pharm; 1986; 38(1):21-8. PubMed ID: 3763484
[TBL] [Abstract][Full Text] [Related]
31. Potentiation of cataleptogenic effects of neuroleptics by prostaglandins.
Herman ZS; Słomińska-Zurek J; Kryk A; Kmieciak-Kołada K
Pol J Pharmacol Pharm; 1978; 30(5):639-46. PubMed ID: 35782
[TBL] [Abstract][Full Text] [Related]
32. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
[TBL] [Abstract][Full Text] [Related]
33. [Effect of narcotic analgesics of nociceptive transmission in the spinal cord].
Kasparov SA
Farmakol Toksikol; 1982; 45(2):30-5. PubMed ID: 6122597
[TBL] [Abstract][Full Text] [Related]
34. Studies on dopamine kinetics in rat brain tissue under the influence of morphine.
Kuschinsky K; Celsen B; Huppertz A
Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):129-33. PubMed ID: 1172489
[TBL] [Abstract][Full Text] [Related]
35. Time course of the enhancement and restoration of the analgesic efficacy of codeine and morphine by delta9-tetrahydrocannabinol.
Williams IJ; Edwards S; Rubo A; Haller VL; Stevens DL; Welch SP
Eur J Pharmacol; 2006 Jun; 539(1-2):57-63. PubMed ID: 16687136
[TBL] [Abstract][Full Text] [Related]
36. Cataleptogenic effect of haloperidol, chlorpromazine and morphine in developing rats.
Brus R; Krzemiński T; Piguła J
Pol J Pharmacol Pharm; 1983; 35(5):377-82. PubMed ID: 6686676
[TBL] [Abstract][Full Text] [Related]
37. Effects of electroconvulsive shock on monoaminergic systems in the rat brain. Thesis.
Wielosz M
Pol J Pharmacol Pharm; 1983; 35(2):127-30. PubMed ID: 6684770
[TBL] [Abstract][Full Text] [Related]
38. A comparison of narcotic analgesics with neuroleptics on behavioral measures of dopaminergic activity.
Lal H; Gianutsos G; Puri SK
Life Sci; 1975 Jul; 17(1):29-34. PubMed ID: 238089
[No Abstract] [Full Text] [Related]
39. The influence of insulin hypoglycemia on central dopaminergic structures of the rat.
Kleinrok Z; Ossowska G; Stelmasiak M; Juszkiewicz M
Pol J Pharmacol Pharm; 1983; 35(6):489-95. PubMed ID: 6377282
[TBL] [Abstract][Full Text] [Related]
40. Participation of prostaglandins in the action of kinins on the central dopaminergic system in the rat. I. The action of kinins on the central dopaminergic system after pretreatment with indomethacin.
Kościelak M; Moniuszko-Jakoniuk J; Wiśniewski K
Pol J Pharmacol Pharm; 1980; 32(3):343-56. PubMed ID: 6912578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
